Sign in

You're signed outSign in or to get full access.

Jon Stansel

Research Analyst at J.P. Morgan

John Stansel is an Equity Research Vice President at JPMorgan Securities LLC, specializing in the medical and healthcare services sector with a focus on companies like Evolent Health and Henry Schein. He covers at least four publicly traded companies, issuing price targets such as $78 on Henry Schein in November 2025, though specific performance metrics like success rates or rankings are not detailed in available data. Stansel joined JPMorgan in 2025 after prior experience at Berenberg Capital, and he holds the CFA designation while being FINRA-registered as a broker with CRD# 7297640.

Jon Stansel's questions to HENRY SCHEIN (HSIC) leadership

Question · Q4 2025

Jon Stansel asked about the cadence of the $125 million run rate contribution from value creation initiatives, specifically if implementation costs in the first half of 2026 would create a headwind and if it would still be a net benefit for the full year.

Answer

Ronald N. South, Senior Vice President and CFO, confirmed that the full year expectation is a net benefit from the initiatives, despite potential lumpiness due to investment timing. He reiterated that the benefit would be more heavily weighted to the second half of the year.

Ask follow-up questions

Fintool

Fintool can predict HENRY SCHEIN logo HSIC's earnings beat/miss a week before the call

Question · Q4 2025

Jon Stansel followed up on the cadence of the $125 million run rate contribution from value creation initiatives, asking if implementation costs in the first half of the year could create a potential headwind early on, and if a net benefit for the full year is still expected.

Answer

Ronald N. South, Senior Vice President and CFO, confirmed that a net benefit is expected for the full year from these initiatives. He noted that there could be some lumpiness in quarterly results due to the timing of investments, with benefits more heavily weighted towards the second half of the year.

Ask follow-up questions

Fintool

Fintool can write a report on HENRY SCHEIN logo HSIC's next earnings in your company's style and formatting